Pfizer in talks to merge off-patent drugs business with Mylan – Reuters

Pfizer in talks to merge off-patent drugs business with Mylan  Reuters

Pfizer Inc is in talks to merge its off-patent drugs business with Mylan NV in a stock deal, the Wall Street Journal reported on Saturday, citing people familiar with …